Bright Minds Biosciences Inc (DRUG)

Financing Cash Flow

-$2.21M

Quarterly · Period ending: · CAD

DRUG logo

DRUG Financing Cash Flow

Latest reported-$2.21M CAD
DRUG Quarterly Cash from Financing · CAD ($60.00 → -$2.21M)
High-resolution chart · PNG

DRUG financing cash flow history

Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bright Minds Biosciences Inc Financing Cash Flow — Quarterly (CAD)
Period endingFinancing Cash Flow (CAD)
-2,208,831
232,495,699
13,390,841
33,318,073
-16,870
225,383
52,040,905
-23,557
-21,957
-21,957
878,043
-21,645
-21,489
-21,490
2,254,310
5,064,256
12,000
1,684
118,250
-9,700
-545,553
24,714,309
1,896,544
926,650
-10,000
91,680
60
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.